Founded Year



Corporate Minority | Alive

Total Raised


Last Raised

$80M | 16 days ago

Mosaic Score

+50 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Owkin

Owkin specializes in AI technologies applied to clinical research with the aim of developing better drugs and treatments for patients. The company's purpose is to empower researchers in hospitals, universities and the biopharma industry to i) understand why drug efficacy varies from patient to patient, ii) improve the drug development process and iii) to help identify key drugs and treatments for each individual patient to improve patient outcomes. The company's precision medicine platform aims to enable medical insights for drug discovery and development by connecting life sciences firms with academic researchers and hospitals. The Owkin platform aims to enable partners to uncover siloed datasets while maintaining patient privacy and securing proprietary data using Federated Learning and innovative collaborative AI technology.

Owkin Headquarter Location

831 Broadway Unit 3R

New York, New York, 10003,

United States

ESPs containing Owkin

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Healthcare / Biopharmaceuticals

Companies in this market offer alternative datasets that can supplement clinical trial data and improve the likelihood of trial success. These companies collect data from a variety of sources, such as patient registries, EHRs, insurance databases, social media, and patient research networks.

Owkin named as Challenger among 15 other companies, including Datavant, Syapse, and Evidation.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Owkin

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Owkin is included in 11 Expert Collections, including Unicorns- Billion Dollar Startups.


Unicorns- Billion Dollar Startups

1,163 items


Clinical Trials Tech

326 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.


AI 100

400 items


Artificial Intelligence

8,718 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.


Digital Health 150

300 items

2019's cohort of the most promising digital health startups transforming the healthcare industry


Biopharma Tech

6,405 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Owkin Patents

Owkin has filed 4 patents.

The 3 most popular patent topics include:

  • Artificial neural networks
  • Classification algorithms
  • Machine learning
patents chart

Application Date

Grant Date


Related Topics



Machine learning, Artificial neural networks, Image processing, Classification algorithms, Computer vision


Application Date


Grant Date


Related Topics

Machine learning, Artificial neural networks, Image processing, Classification algorithms, Computer vision



Latest Owkin News

The Weekly Notable Startup Funding Report: 6/13/22

Jun 13, 2022

AlleyWatch The Weekly Notable Startup Funding Report takes us on a trip across various ecosystems in the US, highlighting some of the notable funding activity in the various markets that we track. The notable startup funding rounds for the week ending 6/11/22 featuring funding details for Vanta, Calaxy, Canix, and twenty other rounds representing $992M in new funding that you need to know about. Aledade $123.0M - Series E Bethesda-based Aledade is a primary care physician platform that provides everything doctors need to create and run an accountable care organization. Founded by Edwin Miller, Farzad Mostashari, and Mat Kendall in 2014, Aledade has now raised a total of $417.9M in total equity funding and is backed by Fidelity Management and Research Company, Infinity Ventures Japan, Meritech Capital Partners, OMERS Growth Equity, and Tiger Global Management. AppOmni $70.0M - Series C San Francisco-based AppOmni is a SaaS security management solution that enables security and IT teams to secure applications used by their employees. Founded by Brendan O'Connor and Brian Soby in 2018, AppOmni has now raised a total of $123.0M in total equity funding and is backed by ClearSky, Costanoa Ventures, Salesforce Ventures, Scale Venture Partners, and Thoma Bravo. Branch $147.0M - Series C Columbus-based Branch is an insurance company focused on instantly providing bundled home and auto insurance. Founded by Joe Emison and Steve Lekas in 2017, Branch has now raised a total of $229.5M in total equity funding and is backed by Acrew, Anthemis Group, Flucas Ventures, Gaingels, Greycroft, HSCM Ventures, Narya Capital, SignalFire, Tower IV, and Weatherford Capital. Calaxy $26.0M - Series A Katy-based Calaxy is the open social marketplace designed & built by Creators for Creators. Founded by Solo Ceesay in 2020, Calaxy has now raised a total of $33.5M in total equity funding and is backed by Animoca Brands, HBAR Foundation, and Polygon Studios. CareAcademy $20.0M - Series B Cambridge-based CareAcademy offers an online training empowering senior care professionals to deliver the highest caliber of services. Founded by Helen Adeosun and Madhuri Reddy in 2013, CareAcademy has now raised a total of $32.2M in total equity funding and is backed by First Trust Capital Partners, Goldman Sachs Asset Management, Impact America Fund, MassMutual, Rethink Education, and Unseen Capital. MarketplaceLIVE is evolving and expanding this year into a hybrid format across several days. Over the three days, you'll be able to engage in global stories, speed network with industry peers, join our first-ever technical user conference, and end with our thought leadership event taking place both virtually and in-person from The Glasshouse in NYC. MarketplaceLIVE is the place where the complete community of cloud and digital stakeholders can come together to learn, cross-pollinate ideas, and network If you're unable to join us in-person, we have you covered with an interactive virtual experience. REGISTER NOW ****The first 10 to register for in-person will receive complimentary registration (valued at $499) use discount code: ALLEYWATCH*** SCiFi Foods $22.0M - Series A San Francisco-based SCiFi Foods works on the next generation of meat alternatives by cultivating meat, instead of harvesting meat from animals. Founded by Jess Krieger, Joshua March, and Kasia Gora in 2019, SCiFi Foods has now raised a total of $22.1M in total equity funding and is backed by Andreessen Horowitz. Encamp $30.0M - Series C Indianapolis-based Encamp specializes in environmental compliance automation, hazardous material tracking, and environmental data management. Founded by Luke Jacobs and Sam Jacobs in 2017, Encamp has now raised a total of $47.2M in total equity funding and is backed by Allos Ventures, Drive Capital, High Alpha, and OpenView. Canix $10.0M - Series A San Francisco-based Canix builds ERP software for cannabis companies Founded by Artem Pasyechnyk and Stacey Hronowski in 2018, Canix has now raised a total of $14.0M in total equity funding and is backed by AltaIR Capital, Cathexis Ventures, and Emles Venture Partners. Kinside $12.0M - Series A Claremont-based Kinside is a developer of a child care flexible spending account designed to automate the claims process. Founded by Abe Han, Brittney Barrett, Rob Bircher, and Shadiah Sigala in 2018, Kinside has now raised a total of $16.6M in total equity funding and is backed by Initialized Capital, Magnify Ventures, Maven Ventures, and Wellington Management. New York-based Ethena is a software-as-a-service that sells anti-harassment training software. Founded by Anne Solmssen and Roxanne Bras Petraeus in 2019, Ethena has now raised a total of $50.4M in total equity funding and is backed by Claire Hughes Johnson, Felicis Ventures, Gretchen Howard, Homebrew, Jack Altman, Lachy Groom, Mathilde Collin, Neo, and William Hockey. AlleyWatch broke the news in an exclusive covering the round and much more - Ethena $30M for its Operating System for Workplace Compliance Training H1 $23.0M - Series C New York-based H1 provides a health data platform to support the end-to-end therapeutic development process of medical companies and healthcare systems. Founded by Ariel Katz and Ian Sax in 2017, H1 has now raised a total of $193.9M in total equity funding and is backed by Goldman Sachs Asset Management, Menlo Ventures, Novartis Pharma, and Transformation Capital. Make an impact on your bottom line and drive leads! The AlleyWatch audience is driving progress and innovation on a global scale. There are a number of options to reach this audience of the world's most innovative organizations and startups at scale including strategic brand placement, lead generation, and thought leadership in front of an audience that comprises the vast majority of key decision-makers in the NYC business community and beyond. Learn more about advertising to NYC Tech, at scale . L7 Informatics $38.0M - Series C Austin-based L7 Informatics provides a workflow management software platform for companies using data-intensive scientific techniques. Founded by Christopher Mueller in 2011, L7 Informatics has now raised a total of $61.1M in total equity funding and is backed by Banneker Partners. Middesk $57.0M - Series B San Francisco-based Middesk is an identity platform that automates business verification and underwrites decisions. Founded by Kurt Ruppel and Kyle Mack in 2018, Middesk has now raised a total of $77.0M in total equity funding and is backed by Accel, Canapi Ventures, Gaingels, Insight Partners, and Sequoia Capital. Nava $40.0M - Series B New York-based Nava provides employee benefits brokerage services with a focus on affordable healthcare. Founded by Brandon Weber, Donald DeSantis, and Kareem Zaki in 2019, Nava has now raised a total of $60.0M in total equity funding and is backed by Avid Ventures, GV, Homebrew, Isha Vij, James Groch, K5 Ventures, Quiet Capital, Sound Ventures, Thrive Capital, and Tom X Lee. OhmConnect $55.0M - Series D San Francisco-based OhmConnect provides a software based powerplant which assists users in reducing their use of electricity. Founded by Curtis Tongue and Matt Duesterberg in 2013, OhmConnect has now raised a total of $83.5M in total equity funding and is backed by Carrier, Citi Impact Fund, City Light Capital, ClearSky, Elemental Excelerator, Floodgate, Japan Energy Fund, Radicle Impact, Sidewalk Infrastructure Partners, SunPower, and TELUS Ventures. Opal $10.0M - Series A San Francisco-based Opal is empowering enterprises to build access management workflows that scale. Founded by Naseem Al-Naji and Stephen Cobbe in 2019, Opal has now raised a total of $11.8M in total equity funding and is backed by Andrew Peterson, base case capital, BoxGroup, Evan Reiser, Grant Miller, Greylock, Joe Morrissey, Joshua Ma, Pedro Canahuati, Philip Martin, and Tim Howes. Owkin $80.0M - Series B New York-based Owkin is an AI precision medicine company with a vision to find the right drug for every patient. Founded by Gilles Wainrib and Thomas Clozel in 2016, Owkin has now raised a total of $334.1M in total equity funding and is backed by Bristol Myers Squibb. You are seconds away from signing up for the hottest list in NYC Tech!

Owkin Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Owkin Rank

  • When was Owkin founded?

    Owkin was founded in 2016.

  • Where is Owkin's headquarters?

    Owkin's headquarters is located at 831 Broadway, New York.

  • What is Owkin's latest funding round?

    Owkin's latest funding round is Corporate Minority.

  • How much did Owkin raise?

    Owkin raised a total of $334.1M.

  • Who are the investors of Owkin?

    Investors of Owkin include Bristol-Myers Squibb, Sanofi Ventures, Plug and Play Accelerator, Bpifrance, Mubadala Capital and 10 more.

  • Who are Owkin's competitors?

    Competitors of Owkin include Bio-AI Health, Unlearn, Savana, ConcertAI, Huma, Nucleai, Decentriq, Holmusk, Lunit, QUIBIM and 22 more.

You May Also Like

Evidation Logo

Evidation measures health in everyday life and enables anyone to participate in research and health programs. Evidation is a two-sided platform that connects individuals and enterprises. On the consumer side, the company assists individuals to participate in research including testing of digital health programs. On the enterprise side, Evidation provides biopharma, med-tech, big tech, academic institutions, professional societies, and government partners the ability to: generate evidence; and design, test, and deploy programs that motivate evidence-based action.

Tempus Logo

Tempus builds a library of molecular and clinical data as well as a corresponding operating system for data accessibility and use. The company enables physicians to deliver personalized cancer care for patients through its interactive analytical and machine learning platform. It provides genomic sequencing services and molecular and therapeutic data analysis to empower physicians to make real-time, data-driven decisions.

Syapse Logo

Syapse develops applications that enable the use of omics profiles in diagnosing and treating patients at diagnostic companies, research institutions, medical centers, and payers. The Syapse Discovery application provides an end-to-end solution for companies and laboratories deploying next-generation sequencing-based diagnostics, from patient sample received to physician report delivered. Discovery's configurable semantic data structure enables users to bring omics data together with traditional medical information to develop and deliver diagnostic tests. The platform's open interfaces enable bioinformaticians and biologists to use their favorite computational tools and annotations.


Paige delivers AI-powered digital diagnostics and biomarkers for pathologists, oncologists, and the R&D community worldwide, while also working closely with biopharma companies to create custom diagnostic solutions and drug development technologies to improve patient care. The firm's target customers include pathologists, hospital leads/chairs as well as life sciences research and translational teams.

Insilico Medicine Logo
Insilico Medicine

Insilico Medicine develops a range of generative adversarial networks (GANs) and reinforcement learning approaches to identify protein targets, generate molecular structures with specified properties, and generate synthetic data. The company provides pharmaceutical and biotechnology companies with artificial intelligence solutions that transform the way innovative medicines and treatments are discovered and accelerate research and development. The company was founded in 2014 and is based in Hong Kong.


BERG is a Boston-based biopharma company focused on taking a bold "back to biology" approach to therapeutic discovery using its unique AI-based Interrogative Biology platform. This platform combines patient biology and artificial intelligence-based analytics to engage the differences between healthy and disease environments. The patient's own biology drives the platform's results and guides the company in the discovery and development of drugs, diagnostics and healthcare applications. Its platform utilizes patient population health data to bring actionable Patient Intelligence to precision medicine applications. This means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.